Story

Moody's Upgrades Teva to Investment Grade on Successful Deleveraging

ENTHMSVIIDZHZH-TWJAKOHI
Aug 11, 20262 min read
Moody's Upgrades Teva to Investment Grade on Successful Deleveraging
Text size
Background

Moody's Ratings has upgraded Teva Pharmaceutical Industries Limited (NYSE:TEVA) to investment grade, lifting the company's issuer rating to Baa3 from Ba1. The ratings agency also revised Teva's outlook to stable from positive, signaling confidence in the drugmaker's financial trajectory.

Rationale for the Upgrade

The upgrade reflects Teva's successful execution of its growth strategy and its commitment to deleveraging its balance sheet. Moody's attributed the decision to a combination of rising sales from branded drugs, an expanding product pipeline, earnings growth, and consistent debt reduction.

The agency noted that it anticipates Teva will continue to reduce its debt over the next 12 to 18 months. This progress is expected to solidify the company's leverage metrics at levels consistent with an investment-grade rating.

Key Financial Metrics

Moody's highlighted several key financial indicators supporting the new rating, forecasting that Teva's leverage will continue to improve.

Sample IUX Markets – In-articleAd
  • Current Leverage: For the 12 months ended June 30, 2026, Teva's gross debt-to-EBITDA ratio was approximately 4.0x, including Moody's adjustments for opioid liabilities.
  • Forward-Looking Target: The agency expects this ratio to decline below 3.75x over the next 12-18 months, driven by debt repayment and earnings growth in 2027.
  • Cash Flow and Liquidity: Teva is projected to generate roughly $2.0 billion of free cash flow over the next year, inclusive of litigation payouts. As of June 30, 2026, the company held approximately $3.7 billion in cash and equivalents and had access to an undrawn $1.8 billion revolving credit facility.

Outlook and Future Triggers

The stable outlook is based on Teva's significant global scale and leading position in generic pharmaceuticals. Moody's also cited improved governance factors, noting that the ongoing deleveraging reduces the company's exposure to financial strategy risks.

The agency provided clear guidance for future rating actions. A sustained gross debt-to-EBITDA ratio above 3.75x could trigger a downgrade, while maintaining the ratio below 3.25x could lead to a future upgrade.

Read next

More on Stocks
Back to latest news

LATEST